Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Makati, Kevin
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Vs Anti-Arrhythmic Drug (AAD) Therapy As a First Line Treatment for Persistent Atrial Fibrillation	Recruiting	N/A	520	Europe, Canada, US, RoW	FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone	Boston Scientific Corporation	Persistent Atrial Fibrillation	12/25	12/27
NCT06170606: POLARx Post Approval Study (POLARx PAS)	Recruiting	N/A	200	US	Boston Scientific Cardiac Cryoablation System	Boston Scientific Corporation	Paroxysmal Atrial Fibrillation	05/26	05/29
NCT05393180: CONVERGE Post-Approval Study (PAS)	Recruiting	N/A	325	Europe, US	Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF	AtriCure, Inc.	Chronic Atrial Fibrillation	11/25	12/25
NCT05280093: HEAL-IST IDE Trial	Recruiting	N/A	142	Europe, US	AtriCure ISOLATOR Synergy Surgical Ablation System	AtriCure, Inc.	Inappropriate Sinus Tachycardia	06/26	06/27